InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $31.190 0.25 (0.80%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$18,527 Announces Sale and Leaseback Arrangement 17 Dec 2007 11:57AM $5.450 $31.190 risen by 472.29%
$18,527 Financial Results for Quarter Ended Sep 30, 2007 2 Nov 2007 9:23AM $5.130 $31.190 risen by 507.99%
$18,527 Appendix 4E and Form 10-K 29 Aug 2007 9:14AM $5.050 $31.190 risen by 517.62%
$18,527 Financial Results for Qtr and Year Ended June 30, 2007 8 Aug 2007 8:48AM $5.100 $31.190 risen by 511.57%
$18,527 Financial Results for Qtr & 9 Months ended 31/03/07 24 Apr 2007 8:40AM $5.080 $31.190 risen by 513.98%
$18,527 Half Yearly Report & Form 10-Q 9 Feb 2007 9:39AM $6.350 $31.190 risen by 391.18%
$18,527 Financial Results for Qtr & 6 Months ended 31/12/06 7 Feb 2007 9:19AM $6.700 $31.190 risen by 365.52%
$18,527 Financial Results for Quarter ended Sept 30 2006 9 Nov 2006 9:55AM $6.060 $31.190 risen by 414.69%
$18,527 Preliminary Final Report & Form 10K 13 Sep 2006 10:03AM $5.390 $31.190 risen by 478.66%
$18,527 Financial Results for Quarter & Year Ended June 30 2006 18 Aug 2006 9:12AM $5.760 $31.190 risen by 441.49%
$18,527 Record Financial Results for March 31 2006 5 May 2006 8:48AM $6.100 $31.190 risen by 411.31%
$18,527 Half Yearly Report/Form 10-Q to 31 December 2005 10 Feb 2006 10:32AM $5.600 $31.190 risen by 456.96%
$18,527 Financial Results for the Qtr & 6 months ended 31/12/05 8 Feb 2006 9:41AM $5.830 $31.190 risen by 434.99%
$18,527 Record Financial Results for quarter ended 30 Sept 2004 3 Nov 2005 10:06AM $5.310 $31.190 risen by 487.38%
$18,527 Completes Launch of S8 Product Platform 18 Oct 2005 10:23AM $5.000 $31.190 risen by 523.80%
$18,527 Appendix 4E & Form 10K for Fiscal Y/E June 30 2005 14 Sep 2005 9:23AM $4.810 $31.190 risen by 548.44%
$18,527 Advice to Participating Orgs: Resmed Inc. Update/Bonus Issue 9 Sep 2005 9:36AM $4.770 $31.190 risen by 553.88%
$18,527 Record Financial Results for Qtr & Y/E 30/06/05 23 Aug 2005 8:41AM $4.670 $31.190 risen by 567.88%
$18,527 Stock Split & Q4F05 Earnings Conference Call 11 Aug 2005 9:28AM $4.330 $31.190 risen by 620.32%
$18,527 To Acquire Saime SA 6 May 2005 9:25AM $3.900 $31.190 risen by 699.74%
$18,527 Acquires Dutch Distributor 15 Dec 2004 9:29AM $3.350 $31.190 risen by 831.04%
$18,527 Record financial quarter results & 9 months ended 31/3/04 27 Apr 2004 8:31AM $3.320 $31.190 risen by 839.46%
$18,527 Record financial quarter results & 9 months ended 31/3/04 27 Apr 2004 8:31AM $3.320 $31.190 risen by 839.46%
$18,527 Half Yearly Report 16 Feb 2004 9:41AM $2.920 $31.190 risen by 968.15%
$18,527 Record Financial Results for Qtr & Six Months ended 31/12/03 5 Feb 2004 8:41AM $2.900 $31.190 risen by 975.52%

676 - 700 of 702 results

Page 28 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.